Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer

The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia.

Carlos L. Arteaga · PubMed · 2001 · 397 citations

Immunology, Pathology, Cancer Biology +19

6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

Hwei‐Ru Tsou, Nellie Mamuya, Bernard D. Johnson et al. · Journal of Medicinal Chemistry · 2001 · 271 citations · Full text

Combinatorial Chemistry, Pharmacotherapy, Pharmaceutical Chemistry +18

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[<i>d</i>]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Jeff B. Smaill, Brian D. Palmer, Gordon W. Rewcastle et al. · Journal of Medicinal Chemistry · 1999 · 178 citations · Full text

Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET

S. Eschmann, Gerald Reischl, K. Bilger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 145 citations

Malignant Thyroid Disorders, Radiation Therapy, Iodine Deficiency Disorders +10

Characterization of the metabolic turnover of epidermal growth factor receptor protein in A‐431 cells

Christa M. Stoscheck, Graham Carpenter · Journal of Cellular Physiology · 1984 · 94 citations